Distribution and metabolism of dihomo-γ-linolenic acid (DGLA, 20:3n-6) by oral supplementation in rats

Bioscience, Biotechnology and Biochemistry

Volumn 70, Issue 9, 2006, Pages 2121-2130

  Umeda Sawada, Rumi ^a,b   Fujiwara, Yoko ^a   Ushiyama, Ikuko ^a   Sagawa, Satoe ^a   Morimitsu, Yasujiro ^a   Kawashima, Hiroshi ^c   Ono, Yoshiko ^c   Kiso, Yoshinobu ^c   Matsumoto, Akiyo ^d   Seyama, Yousuke ^a  

^a OCHANOMIZU UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^c SUNTORY LTD   (Japan)

^d JOSAI UNIVERSITY   (Japan)

Author keywords

Arachidonic acid; Delta 5 and delta 6 desaturase; Dihomo linolenic acid (DGLA); Rat

Indexed keywords

ARACHIDONIC ACID; DELTA 5 / 6 DESATURASE; DIHOMO-Γ-LINOLENIC ACID (DGLA); RATS;

DERMATITIS; FUNGI; MEDICINE; METABOLISM; NUTRITION; OILS AND FATS;

FATTY ACIDS;

ACYL COENZYME A DESATURASE; DELTA 5 FATTY ACID DESATURASE; DELTA-5 FATTY ACID DESATURASE; DIHOMO GAMMA LINOLENIC ACID; GAMMA LINOLENIC ACID; LINOLEOYL COENZYME A DESATURASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROSTAGLANDIN E1; PROSTAGLANDIN E2; STEROL REGULATORY ELEMENT BINDING PROTEIN;

ANIMAL; ARTICLE; ATOPIC DERMATITIS; BIOSYNTHESIS; BLOOD; BRAIN; COMPARATIVE STUDY; GENETICS; LIVER; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WISTAR RAT;

8,11,14-EICOSATRIENOIC ACID; ADMINISTRATION, ORAL; ALPROSTADIL; ANIMALS; BRAIN; DERMATITIS, ATOPIC; DINOPROSTONE; FATTY ACID DESATURASES; GAMMA-LINOLENIC ACID; LINOLEOYL-COA DESATURASE; LIVER; MALE; PPAR ALPHA; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEINS;

BORAGINACEAE; FUNGI; RATTUS NORVEGICUS; ZEA MAYS;

EID: 33749028706     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.60057     Document Type: Article

References (49)

1. Zurier, R. B., and Quagliate, F., Effect of prostaglandin E1 on adjuvant arthritis. Nature, 234, 304-305 (1971).
2. Zurier, R. B., Sayadoffm, D. M., Torreym, S. B., and Rothfield, N. F., Prostaglandin E treatment in NZB/NZW mice. Arthritis Rheum., 20, 723-728 (1977).
3. Zurier, R. B., Prostaglandins, immune responses, and murine lupus. Arthritis Rheum., 25, 804-809 (1982).
4. Kloeze, J., Relationship between chemical structure and platelet-aggregation activity of prostaglandins. Biochim. Biophys. Acta, 187, 285-292 (1969).
5. Nakamura, N., Hamazaki, T., Taki, H., Yamazaki, K., and Kobayashi, M., Intravenous infusion of tridihomo-gamma-linolenoyl-glycerol reduces leukotriene B4 production in the rat and rabbit. Clin. Sci. (Lond), 84, 511-516 (1993).
6. Smith, D. L., Willis, A. L., Nguyen, N., Conner, D., Zahedi, S., and Fulks, J., Eskimo plasma constituents, dihomo-gamma-linolenic acid, eicosapentaenoic acid and docosahexaenoic acid, inhibit the release of atherogenic mitogens. Lipids, 24, 70-75 (1989).
7. Hassall, C. H., and Kirtland, S. J., Dihomo-gamma-linolenic acid reverses hypertension induced in rats by diets rich in saturated fat. Lipids, 19, 699-703 (1984).
8. Taki, H., Nakamura, N., Hamazaki, T., and Kobayashi, M., Intravenous injection of tridihomo-gamma-linolenoyl-glycerol into mice and its effects on delayed-type hypersensitivity. Lipids, 28, 873-876 (1993).
9. Wright, S., and Burton, J. L., Oral evening-primrose-seed oil improves atopic eczema. Lancet, 2, 1120-1122 (1982).
10. Schalin-Karrila, M., Mattila, L., Jansen, C. T., and Uotila, P., Evening primrose oil in the treatment of atopic eczema: effect on clinical status, plasma phospholipid fatty acids and circulating blood prostaglandins. Br. J. Dermatol., 117, 11-19 (1987).
11. Henz, B. M., Jablonska, S., van de Kerkhof, P. C., Stingl, G., Blaszczyk, M., Vandervalk, P. G., Veenhuizen, R., Muggli, R., and Raederstorff, D., Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema. Br. J. Dermatol., 140, 685-688 (1999).
12. Yoshimoto-Furuie, K., Yoshimoto, K., Tanaka, T., Saima, S., Kikuchi, Y., Shay, J., Horrobin, D. F., and Echizen, H., Effects of oral supplementation with evening primrose oil for six weeks on plasma essential fatty acids and uremic skin symptoms in hemodialysis patients. Nephron, 81, 151-159 (1999).
13. Dickerson, L. M., Mazyck, P. J., and Hunter, M. H., Premenstrual syndrome. Am. Fam. Physician, 67, 1743-1752 (2003).
14. Horrobin, D. F., The role of essential fatty acids and prostaglandins in the premenstrual syndrome. J. Reprod. Med., 28, 465-468 (1983).
15. Horrobin, D. F., Evening primrose oil and premenstrual syndrome. Med. J. Aust., 153, 630-631 (1990).
16. Danon, A., Heimberg, M., and Oates, J. A., Enrichment of rat tissue lipids with fatty acids that are prostaglandin precursors. Biochim. Biophys. Acta, 388, 318-330 (1975).
17. Oelz, O., Seyberth, H. W., Knapp, Jr., H. R., Sweetman, B. J., and Oates, J. A., Effects of feeding ethyl-dihomo-gamma-linolenate on prostaglandin biosynthesis and platelet aggregation in the rabbit. Biochim. Biophys. Acta, 431, 268-277 (1976).
18. Knapp, H. R., Oelz, O., Whorton, A. R., and Oates, J. A., Effects of feeding ethyl-dihomo-gamma-linolenate on rabbit renomedullary lipid composition and prostaglandin production in vitro. Lipids, 13, 804-808 (1978).
19. Kawashima, H., Akimoto, K., Higashiyama, K., Fujikawa, S., and Shimizu, S., Industrial production of dihomo-γ-linolenic acid by Δ5 desaturase-defective mutant of mortierella alpine 1S-4 fungs. JAOCS, 77, 1135-1138 (2000).
20. Bieri, J., Stoewsand, G., Briggs, G., Phllis, R., Woodard, J., and Knapka, J., Report of the American Institute of Nutrition ad hoc committee on standards for nutritional studies. J. Nutr., 107, 1340-1348 (1977).
21. Folch, J., Lees, M., and Sloan Stanley, G. H., A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem., 226, 497-509 (1957).
22. Fujiyama-Fujiwara, Y., Ohmori, C., and Igarashi, O., Metabolism of gamma-linolenic acid in primary cultures of rat hepatocytes and in Hep G2 cells. J. Nutr. Sci. Vitaminol. (Tokyo), 35, 597-611 (1989).
23. Ozeki, Y., Sudo, T., Toga, K., Nagamura, Y., Ito, H., Ogawa, T., and Kimura, Y., Characterization of whole blood aggregation with a new type of aggregometer by a screen filtration pressure method. Thrombosis Research, 101, 65-72 (2001).
24. Ikeda, I., Sasaki, E., Yasunami, H., Nomiyama, S., Nakayama, M., Sugano, M., Imaizumi, K., and Yazawa, K., Digestion and lymphatic transport of eicosapentaenoic and docosahexaenoic acids given in the form of triacylglycerol, free acid and ethyl ester in rats. Biochim. Biophys. Acta, 1259, 297-304 (1995).
25. Bishop-Bailey, D., Pepper, J. R., Haddad, E. B., Newton, R., Larkin, S. W., and Mitchell, J. A., Induction of cyclooxygenase-2 in human saphenous vein and internal mammary artery. Arterioscler. Thromb. Vasc. Biol., 17, 1644-1648 (1997).
26. Matsumoto, H., Naraba, H., Murakami, M., Kudo, I., Yamaki, K., Ueno, A., and Ohishi, S., Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rat peritoneal macrophages. Biochem. Biophys. Res. Commun., 230, 110-114 (1997).
27. Brock, T. G., McNish, R. W., and Peters-Golden, M., Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2. J. Biol. Chem., 274, 11660-11666 (1999).
28. Bennett, A., Tacca, M. D., Stamford, I. F., and Zebro, T., Prostaglandins from tumours of human large bowel. Br. J. Cancer, 35, 881-884 (1977).
29. Narisawa, T., Kusaka, H., Yamazaki, Y., Takahashi, M., Koyama, H., Koyama, K., Fukaura, Y., and Wakizaka, A., Relationship between blood plasma prostaglandin E2 and liver and lung metastases in colorectal cancer. Dis. Colon Rectum, 33, 840-845 (1990).
30. Jelinska, M., Tokarz, A., Oledzka, R., and Czorniuk-Sliwa, A., Effects of dietary linseed, evening primrose or fish oils on fatty acid and prostaglandin E2 contents in the rat livers and 7,12-dimethylbenz[a]anthracene-induced tumours. Biochim. Biophys. Acta, 1637, 193-199 (2003).
31. Hidalgo, G. E., Zhong, L., Doherty, D. E., and Hirschowitz, E. A., Plasma PGE-2 levels and altered cytokine profiles in adherent peripheral blood mononuclear cells in non-small cell lung cancer (NSCLC). Mol. Cancer, 1, 5 (2002).
32. Zurier, R. B., and Quagliata, F., Effect of prostaglandin E 1 on adjuvant arthritis. Nature, 234, 304-305 (1971).
33. Zurier, R. B., Sayadoff, D. M., Torrey, A. B., and Rothfield, N. F., Prostaglandin E treatment of NZB/NZW mice. Arthritis Rheum., 20, 723-728 (1977).
34. Zurier, R. B., Prostaglandins, immune responses, and murine lupus. Arthritis Rheum., 25, 804-809 (1982).
35. Ziboh, V. A., The significance of polyunsaturated fatty acids in cutaneous biology. Lipids, 31 (Suppl), S249-253 (1996).
36. Levin, G., Duffin, K. L., Obukowicz, M. G., Hummert, S. L., Fujiwara, H., Needleman, P., and Raz, A., Differential metabolism of dihomo-gamma-linolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2: implications for cellular synthesis of prostaglandin E1 and prostaglandin E2. Biochem. J., 365, 489-496 (2002).
37. Matsuzaka, T., Shimano, H., Yahagi, N., Amemiya-Kudo, M., Yoshikawa, T., Hasty, A. H., Tamura, Y., Osuga, J., Okazaki, H., Iizuka, Y., Takahashi, A., Sone, H., Gotoda, T., Ishibashi, S., and Yamada, N., Dual regulation of mouse delta(5)- and delta(6)-desaturase gene expression by SREBP-1 and PPARalpha. J. Lipid Res., 43, 107-114 (2002).
38. Tang, C., Cho, H. P., Nakamura, M. T., and Clarke, S. D., Regulation of human delta-6 desaturase gene transcription: identification of a functional direct repeat-1 element. J. Lipid Res., 44, 686-695 (2003).
39. de Urquiza, A. M., Liu, S., Sjoberg, M., Zetterstrom, R. H., Griffiths, W., Sjovall, J., and Perlmann, T., Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science, 290, 2140-2144 (2000).
40. Fan, Y. Y., Spencer, T. E., Wang, N., Moyer, M. P., and Chapkin, R. S., Chemopreventive n-3 fatty acids activate RXRalpha in colonocytes. Carcinogenesis, 24, 1541-1548 (2003).
41. Fujiwara, Y., Yokoyama, M., Sawada, R., Seyama, Y., Ishii, M., Tsutsumi, S., Aburatani, H., Hanaka, S., Itakura, H., and Matsumoto, A., Analysis of the comprehensive effects of polyunsaturated fatty acid on mRNA expression using a gene chip. J. Nutr. Sci. Vitaminol. (Tokyo), 49, 125-132 (2003).
42. Berger, A., Mutch, D. M., German, J. B., and Roberts, M. A., Dietary effects of arachidonate-rich fungal oil and fish oil on murine hepatic and hippocampal gene expression. Lipids Health Dis., 1, 2 (2002).
43. Yoshikawa, T., Shimano, H., Yahagi, N., Ide, T., Amemiya-Kudo, M., Matsuzaka, T., Nakakuki, M., Tomita, S., Okazaki, H., Tamura, Y., Iizuka, Y., Ohashi, K., Takahashi, A., Sone, H., Osuga, J., Gotoda, T., Ishibashi, S., and Yamada, N., Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J. Biol. Chem., 277, 1705-1711 (2002).
44. Worgall, T. S., Sturley, S. L., Seo, T., Osborne, T. F., and Deckelbaum, R. J., Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element-binding protein. J. Biol. Chem., 273, 25537-25540 (1998).
45. Torra, I. P., Jamshidi, Y., Flavell, D. M., Fruchart, J. C., and Steals, B., Characterization of the human PPARα promoter: identification of a functional nuclear receptor response element. Mol. Endocrinol., 16, 1013-1028 (2002).
46. Torra, I. P., Claudel, T., Duval, C., Kosykh, V., Fruchart, J. C., and Steals, B., Bile acid induces the expression of the human peroxisome proliferator-activated receptor α gene via activation of the farnesoid X receptor. Mol. Endocrinol., 17, 259-272 (2003).
47. Lemberger, T., Steals, B., Saladin, R., Desvergne, B., Auwerx, J., and Wahli, W., Regulation of the peroxisome proliferator-activated receptor α gene by glucocorticoids. J. Biol. Chem., 269, 24527-24530 (1994).
48. Hayhurst, G., Lee, Y. H., Lambert, G., Ward, J. M., and Gonzalez, F., Hepatocyte nuclear factor 4a (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol. Cell. Biol., 21, 1393-1403 (2001).
49. Rajas, F., Gautier, A., Bady, I., Montano, S., and Mithieux, G., Polyunsaturated fatty acyl coenzyme A suppresses the glucose-6-phosphatase promoter activity by modulating the DNA binding of hepatocyte nuclear factor 4α. J. Biol. Chem., 277, 15736-15744 (2002).